Nurami Medical · raw details

Modernizing Soft Tissue Repair · Haifa · Founded 2014

active Series B ← back to profile

Highlights

IIA supported (ever)1 patentProfile claimed by owner

About

Modernizing Soft Tissue Repair

Nurami harnesses nanofibers and novel biomaterials to modernize soft tissue surgical repair. Nurami’s proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. These advanced products address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation such as Dura repair as well as other tissue recovery processes.

Nurami's first soft-tissue repair product, ArtiFascia, is a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. ArtiFascia is available for commercial use in the USA and has FDA 510(k) clearance.

Identity

NameNurami Medical
Slugnurami-medical
Type / kindstartup
Crunchbase IDnurami-medical
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6k-9sJDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtNorth District
HQ cityHaifa
HQ addressHa-Namal Street 36, Haifa, Israel

Web & social

Websitehttps://www.nurami-medical.com
Careers pagehttps://www.nurami-medical.com/company/careers
LinkedInhttps://www.linkedin.com/company/5222266
Facebookhttps://www.facebook.com/Nurami-Medical-111635057259570

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesNanomaterialsPolymersImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnology
Business models
B2B
Tags
surgeonsbiodegradablenanotechnologysurgeryneurologydoctorshospitalsmedical-technologiesregenerative-medicinefibersneurosurgerylife-sciencesmedical-devicesbiotechnologybiomaterialstissue-regeneration

Funding

Total raised$43.6M
Current stageSeries B

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}